Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants

Despite successful treatments, hepatitis C virus (HCV) infections continue to be a significant world health problem. High treatment costs, the high number of undiagnosed individuals, and the difficulty to access to treatment, particularly in marginalized susceptible populations, make it improbable t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepulveda-Crespo, Daniel, Resino, Salvador, Martinez, Isidoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350220/
https://www.ncbi.nlm.nih.gov/pubmed/32560440
http://dx.doi.org/10.3390/vaccines8020313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350220/
https://www.ncbi.nlm.nih.gov/pubmed/32560440
http://dx.doi.org/10.3390/vaccines8020313

Ejemplares similares